The Market Reports

Index

1 Inhalable Drugs Market Overview
1.1 Product Overview and Scope of Inhalable Drugs
1.2 Inhalable Drugs Segment by Type
1.2.1 Global Inhalable Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Suspension Aerosol
1.2.3 Solution Aerosol
1.2.4 Dry Powder Formulation
1.3 Inhalable Drugs Segment by Application
1.3.1 Global Inhalable Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Respiratory Diseases
1.3.3 Non-respiratory Diseases
1.4 Global Inhalable Drugs Market Size Estimates and Forecasts
1.4.1 Global Inhalable Drugs Revenue 2016-2027
1.4.2 Global Inhalable Drugs Sales 2016-2027
1.4.3 Inhalable Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Inhalable Drugs Market Competition by Manufacturers
2.1 Global Inhalable Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Inhalable Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Inhalable Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Inhalable Drugs Manufacturing Sites, Area Served, Product Type
2.5 Inhalable Drugs Market Competitive Situation and Trends
2.5.1 Inhalable Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Inhalable Drugs Players Market Share by Revenue
2.5.3 Global Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhalable Drugs Retrospective Market Scenario by Region
3.1 Global Inhalable Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Inhalable Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Inhalable Drugs Market Facts & Figures by Country
3.3.1 North America Inhalable Drugs Sales by Country
3.3.2 North America Inhalable Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhalable Drugs Market Facts & Figures by Country
3.4.1 Europe Inhalable Drugs Sales by Country
3.4.2 Europe Inhalable Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhalable Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Inhalable Drugs Sales by Region
3.5.2 Asia Pacific Inhalable Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhalable Drugs Market Facts & Figures by Country
3.6.1 Latin America Inhalable Drugs Sales by Country
3.6.2 Latin America Inhalable Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Inhalable Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhalable Drugs Sales by Country
3.7.2 Middle East and Africa Inhalable Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Inhalable Drugs Historic Market Analysis by Type
4.1 Global Inhalable Drugs Sales Market Share by Type (2016-2021)
4.2 Global Inhalable Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Inhalable Drugs Price by Type (2016-2021)

5 Global Inhalable Drugs Historic Market Analysis by Application
5.1 Global Inhalable Drugs Sales Market Share by Application (2016-2021)
5.2 Global Inhalable Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Inhalable Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 NanoDerma
6.1.1 NanoDerma Corporation Information
6.1.2 NanoDerma Description and Business Overview
6.1.3 NanoDerma Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 NanoDerma Inhalable Drugs Product Portfolio
6.1.5 NanoDerma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Inhalable Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Aradigm Corporation
6.3.1 Aradigm Corporation Corporation Information
6.3.2 Aradigm Corporation Description and Business Overview
6.3.3 Aradigm Corporation Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aradigm Corporation Inhalable Drugs Product Portfolio
6.3.5 Aradigm Corporation Recent Developments/Updates
6.4 Alkerme
6.4.1 Alkerme Corporation Information
6.4.2 Alkerme Description and Business Overview
6.4.3 Alkerme Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Alkerme Inhalable Drugs Product Portfolio
6.4.5 Alkerme Recent Developments/Updates
6.5 Dura Pharmaceuticals
6.5.1 Dura Pharmaceuticals Corporation Information
6.5.2 Dura Pharmaceuticals Description and Business Overview
6.5.3 Dura Pharmaceuticals Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Dura Pharmaceuticals Inhalable Drugs Product Portfolio
6.5.5 Dura Pharmaceuticals Recent Developments/Updates
6.6 AeroGen and Inhale Therapeutic Systems
6.6.1 AeroGen and Inhale Therapeutic Systems Corporation Information
6.6.2 AeroGen and Inhale Therapeutic Systems Description and Business Overview
6.6.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product Portfolio
6.6.5 AeroGen and Inhale Therapeutic Systems Recent Developments/Updates

7 Inhalable Drugs Manufacturing Cost Analysis
7.1 Inhalable Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhalable Drugs
7.4 Inhalable Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhalable Drugs Distributors List
8.3 Inhalable Drugs Customers

9 Inhalable Drugs Market Dynamics
9.1 Inhalable Drugs Industry Trends
9.2 Inhalable Drugs Growth Drivers
9.3 Inhalable Drugs Market Challenges
9.4 Inhalable Drugs Market Restraints

10 Global Market Forecast
10.1 Inhalable Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhalable Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Inhalable Drugs by Type (2022-2027)
10.2 Inhalable Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhalable Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Inhalable Drugs by Application (2022-2027)
10.3 Inhalable Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhalable Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Inhalable Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Inhalable Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Inhalable Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Inhalable Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Inhalable Drugs Covered in This Study
Table 5. Global Inhalable Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Inhalable Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Inhalable Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Inhalable Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Inhalable Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Inhalable Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Inhalable Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inhalable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalable Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Inhalable Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Inhalable Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Inhalable Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Inhalable Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Inhalable Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Inhalable Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Inhalable Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Inhalable Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Inhalable Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Inhalable Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Inhalable Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Inhalable Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Inhalable Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Inhalable Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Inhalable Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Inhalable Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Inhalable Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Inhalable Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Inhalable Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Inhalable Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Inhalable Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Inhalable Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Inhalable Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Inhalable Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Inhalable Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Inhalable Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Inhalable Drugs Revenue Share by Type (2016-2021)
Table 42. Global Inhalable Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Inhalable Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Inhalable Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Inhalable Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Inhalable Drugs Revenue Share by Application (2016-2021)
Table 47. Global Inhalable Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. NanoDerma Corporation Information
Table 49. NanoDerma Description and Business Overview
Table 50. NanoDerma Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. NanoDerma Inhalable Drugs Product
Table 52. NanoDerma Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Inhalable Drugs Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Aradigm Corporation Corporation Information
Table 59. Aradigm Corporation Description and Business Overview
Table 60. Aradigm Corporation Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Aradigm Corporation Inhalable Drugs Product
Table 62. Aradigm Corporation Recent Developments/Updates
Table 63. Alkerme Corporation Information
Table 64. Alkerme Description and Business Overview
Table 65. Alkerme Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Alkerme Inhalable Drugs Product
Table 67. Alkerme Recent Developments/Updates
Table 68. Dura Pharmaceuticals Corporation Information
Table 69. Dura Pharmaceuticals Description and Business Overview
Table 70. Dura Pharmaceuticals Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Dura Pharmaceuticals Inhalable Drugs Product
Table 72. Dura Pharmaceuticals Recent Developments/Updates
Table 73. AeroGen and Inhale Therapeutic Systems Corporation Information
Table 74. AeroGen and Inhale Therapeutic Systems Description and Business Overview
Table 75. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product
Table 77. AeroGen and Inhale Therapeutic Systems Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Inhalable Drugs Distributors List
Table 81. Inhalable Drugs Customers List
Table 82. Inhalable Drugs Market Trends
Table 83. Inhalable Drugs Growth Drivers
Table 84. Inhalable Drugs Market Challenges
Table 85. Inhalable Drugs Market Restraints
Table 86. Global Inhalable Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 87. Global Inhalable Drugs Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Inhalable Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Inhalable Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Inhalable Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 91. Global Inhalable Drugs Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Inhalable Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Inhalable Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Inhalable Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 95. Global Inhalable Drugs Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Inhalable Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Inhalable Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhalable Drugs
Figure 2. Global Inhalable Drugs Market Share by Type in 2020 & 2027
Figure 3. Suspension Aerosol Product Picture
Figure 4. Solution Aerosol Product Picture
Figure 5. Dry Powder Formulation Product Picture
Figure 6. Global Inhalable Drugs Market Share by Application in 2020 & 2027
Figure 7. Respiratory Diseases
Figure 8. Non-respiratory Diseases
Figure 9. Global Inhalable Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Inhalable Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Inhalable Drugs Sales 2016-2027 (K Units)
Figure 12. Global Inhalable Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Inhalable Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Inhalable Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Inhalable Drugs Players: Market Share by Revenue in 2020
Figure 16. Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Inhalable Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Inhalable Drugs Sales Market Share by Region in 2020
Figure 19. Global Inhalable Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Inhalable Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Inhalable Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Inhalable Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Inhalable Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Inhalable Drugs by Application in 2020
Figure 48. Revenue Share of Inhalable Drugs by Application (2016-2021)
Figure 49. Revenue Share of Inhalable Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Inhalable Drugs
Figure 51. Manufacturing Process Analysis of Inhalable Drugs
Figure 52. Inhalable Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed